Absolute configuration and psychotomimetic activity
- PMID: 101890
Absolute configuration and psychotomimetic activity
Similar articles
-
Differences between the mechanism of action of MDMA, MBDB, and the classic hallucinogens. Identification of a new therapeutic class: entactogens.J Psychoactive Drugs. 1986 Oct-Dec;18(4):305-13. doi: 10.1080/02791072.1986.10472362. J Psychoactive Drugs. 1986. PMID: 2880944 Review. No abstract available.
-
(+)-N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine as a discriminative stimulus in studies of 3,4-methylenedioxy-methamphetamine-like behavioral activity.J Pharmacol Exp Ther. 1990 Dec;255(3):1098-106. J Pharmacol Exp Ther. 1990. PMID: 1979813
-
Resolution and absolute configuration of trans-2-(2,5-dimethoxy-4-methylphenyl)cyclopropylamine, a potent hallucinogen analogue.J Med Chem. 1979 Apr;22(4):458-60. doi: 10.1021/jm00190a021. J Med Chem. 1979. PMID: 430485
-
CB1 cannabinoid receptor modulates 3,4-methylenedioxymethamphetamine acute responses and reinforcement.Biol Psychiatry. 2008 Jun 1;63(11):1030-8. doi: 10.1016/j.biopsych.2007.09.003. Epub 2007 Oct 24. Biol Psychiatry. 2008. PMID: 17950256
-
Use of drug discrimination in drug abuse research.NIDA Res Monogr. 1991;(116):369-97. doi: 10.1037/e496182006-023. NIDA Res Monogr. 1991. PMID: 1369679 Review. No abstract available.
Cited by
-
Drug discrimination studies with MDMA and amphetamine.Psychopharmacology (Berl). 1988;95(1):71-6. doi: 10.1007/BF00212770. Psychopharmacology (Berl). 1988. PMID: 2898791
-
MDMA (Ecstasy) and human dopamine, norepinephrine, and serotonin transporters: implications for MDMA-induced neurotoxicity and treatment.Psychopharmacology (Berl). 2007 Jan;189(4):489-503. doi: 10.1007/s00213-005-0174-5. Epub 2005 Oct 12. Psychopharmacology (Berl). 2007. PMID: 16220332
-
Dark Classics in Chemical Neuroscience: 3,4-Methylenedioxymethamphetamine.ACS Chem Neurosci. 2018 Oct 17;9(10):2408-2427. doi: 10.1021/acschemneuro.8b00155. Epub 2018 Jul 12. ACS Chem Neurosci. 2018. PMID: 30001118 Free PMC article. Review.
-
Preliminary evidence of hippocampal dysfunction in adolescent MDMA ("ecstasy") users: possible relationship to neurotoxic effects.Psychopharmacology (Berl). 2004 May;173(3-4):383-90. doi: 10.1007/s00213-003-1679-4. Epub 2003 Nov 28. Psychopharmacology (Berl). 2004. PMID: 14647960
-
Acute effects of R-MDMA, S-MDMA, and racemic MDMA in a randomized double-blind cross-over trial in healthy participants.Neuropsychopharmacology. 2024 Dec;50(2):362-371. doi: 10.1038/s41386-024-01972-6. Epub 2024 Aug 23. Neuropsychopharmacology. 2024. PMID: 39179638 Free PMC article. Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources